Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2026-02-03 @ 4:17 PM
Study NCT ID:
NCT02233712
Status:
COMPLETED
Last Update Posted:
2014-09-08
First Post:
2014-08-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.
Sponsor:
Cancer Advances Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GC3
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None